Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma

NCT03598595 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Osteosarcoma
Refractory Osteosarcoma

Interventions

DRUG: Docetaxel
DRUG: Gemcitabine
DRUG: Hydroxychloroquine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]